BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6148350)

  • 1. High-performance liquid chromatographic assay for the major blood metabolite of esmolol--an ultra short acting beta blocker.
    Stampfli HF; Lai CM; Yacobi A; Sum CY
    J Chromatogr; 1984 Jul; 309(1):203-8. PubMed ID: 6148350
    [No Abstract]   [Full Text] [Related]  

  • 2. Gas chromatographic-mass spectrometric assay for the ultra-short-acting beta-blocker esmolol.
    Sum CY; Yacobi A
    J Pharm Sci; 1984 Aug; 73(8):1177-9. PubMed ID: 6149299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and rapid high-performance liquid chromatographic assay for esmolol.
    Fan CD; Zhao H; Chow MS
    J Chromatogr; 1991 Sep; 570(1):217-23. PubMed ID: 1686774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of the enantiomers of esmolol and its acid metabolite in human plasma by reversed phase liquid chromatography with solid-phase extraction.
    Tang YH; He Y; Yao TW; Zeng S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):249-54. PubMed ID: 15135097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-electrospray mass spectrometry (LC-MS) method for determination of esmolol concentration in human plasma.
    Zuppa AF; Shi H; Adamson PC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):293-301. PubMed ID: 14581069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of carboxybupranolol, the major metabolite of bupranolol, in human plasma by high-performance liquid chromatography.
    Walmsley LM; Brodie RR; Chasseaud LF
    J Chromatogr; 1984 Nov; 311(1):227-33. PubMed ID: 6151568
    [No Abstract]   [Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay for determination of a new beta-blocking agent FM 24.
    Lefebvre MA; Julian B; Fourtillan JB
    J Chromatogr; 1982 Jun; 230(1):199-202. PubMed ID: 6125522
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of esmolol in human blood by high-performance liquid chromatography and its application to pharmacokinetic studies.
    Achari R; Drissel D; Thomas D; Shin K; Look Z
    J Chromatogr; 1988 Feb; 424(2):430-4. PubMed ID: 2897375
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic method for the determination of carazolol in serum or plasma of pigs.
    Kadir F; Zuidema J
    J Chromatogr; 1990 May; 527(2):461-6. PubMed ID: 1974898
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitation of the ultra short acting beta-adrenergic antagonist flestolol in blood by liquid chromatography.
    Moore P; Mai K; Lai CM
    J Pharm Sci; 1986 Apr; 75(4):424-6. PubMed ID: 2873234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of esmolol in serum by capillary zone electrophoresis and its monitoring in course of heart surgery.
    Malovaná S; Gajdosová D; Benedík J; Havel J
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):37-43. PubMed ID: 11522064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and urinary excretion of esmolol in humans.
    Achari R; Drissel D; Matier WL; Hulse JD
    J Clin Pharmacol; 1986 Jan; 26(1):44-7. PubMed ID: 2869058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple method for routine determination of betaxolol in blood and urine by automated high-performance liquid chromatography with fluorimetric detection.
    Caqueret H; Bianchetti G
    J Chromatogr; 1984 Nov; 311(1):199-205. PubMed ID: 6151567
    [No Abstract]   [Full Text] [Related]  

  • 14. High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids.
    Reiff K
    J Chromatogr; 1987 Jan; 413():355-62. PubMed ID: 2881938
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of betaxolol in plasma by high-performance liquid chromatography with fluorescence detection.
    Canal M; Flouvat B
    J Chromatogr; 1985 Jul; 342(1):212-5. PubMed ID: 2864353
    [No Abstract]   [Full Text] [Related]  

  • 16. Column liquid chromatographic measurement of betaxolol in plasma or serum.
    Bhamra RK; Ward AE; Holt DW
    J Chromatogr; 1987 Jun; 417(1):229-32. PubMed ID: 2887581
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite.
    Sum CY; Yacobi A; Kartzinel R; Stampfli H; Davis CS; Lai CM
    Clin Pharmacol Ther; 1983 Oct; 34(4):427-34. PubMed ID: 6617063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sensitive high-performance liquid chromatographic determination of bisoprolol in plasma and urine.
    Poirier JM; Perez M; Cheymol G; Jaillon P
    J Chromatogr; 1988 Apr; 426(2):431-7. PubMed ID: 2899087
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of temperature on in vitro metabolism of esmolol.
    Melendez JA; Stone JG; Delphin E; Quon CY
    J Cardiothorac Anesth; 1990 Dec; 4(6):704-6. PubMed ID: 1983408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dodecyl sulfate as an esterase inhibitor before gas-chromatographic determination of labile beta-adrenoceptor blocking drugs.
    Holm G; Kylberg-Hanssen K; Svensson L
    Clin Chem; 1985 Jun; 31(6):868-70. PubMed ID: 2859935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.